Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson’s disease and Lewy body dementia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson’s disease and Lewy body dementia ; volume:12 ; number:1 ; day:20 ; month:10 ; year:2022 ; pages:1-11 ; date:12.2022
Scientific reports ; 12, Heft 1 (20.10.2022), 1-11, 12.2022
- Urheber
-
Asghar, Muhammad
Odeh, Amani
Fattahi, Ahmad Jouni
Henriksson, Alexandra Edwards
Miglar, Aurelie
Khosousi, Shervin
Svenningsson, Per
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-22400-z
- URN
-
urn:nbn:de:101:1-2023010521021574833643
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Asghar, Muhammad
- Odeh, Amani
- Fattahi, Ahmad Jouni
- Henriksson, Alexandra Edwards
- Miglar, Aurelie
- Khosousi, Shervin
- Svenningsson, Per
- SpringerLink (Online service)
Ähnliche Objekte (12)
T lymphocyte senescence is attenuated in Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
Abnormalities of age-related T cell senescence in Parkinson’s disease
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
LRRK2 in Parkinson's disease and dementia with Lewy bodies
The enzymatic core of the Parkinson’s disease-associated protein LRRK2 impairs mitochondrial biogenesis in aging yeast
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
T lymphocyte senescence is attenuated in Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
Abnormalities of age-related T cell senescence in Parkinson’s disease
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
LRRK2 in Parkinson's disease and dementia with Lewy bodies
The enzymatic core of the Parkinson’s disease-associated protein LRRK2 impairs mitochondrial biogenesis in aging yeast
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
T lymphocyte senescence is attenuated in Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
Abnormalities of age-related T cell senescence in Parkinson’s disease
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
LRRK2 in Parkinson's disease and dementia with Lewy bodies
The enzymatic core of the Parkinson’s disease-associated protein LRRK2 impairs mitochondrial biogenesis in aging yeast
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia